Prothena Corp PLC (PRTA)
23.05
-0.48
(-2.04%)
USD |
NASDAQ |
May 08, 16:00
23.05
0.00 (0.00%)
After-Hours: 19:05
Prothena 1 Year Total Returns (Daily): -70.06% for May 7, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 07, 2024 | -70.06% |
May 06, 2024 | -69.79% |
May 03, 2024 | -65.81% |
May 02, 2024 | -58.03% |
May 01, 2024 | -60.19% |
April 30, 2024 | -61.35% |
April 29, 2024 | -59.73% |
April 26, 2024 | -60.87% |
April 25, 2024 | -62.09% |
April 24, 2024 | -62.47% |
April 23, 2024 | -62.29% |
April 22, 2024 | -60.95% |
April 19, 2024 | -60.18% |
April 18, 2024 | -61.28% |
April 17, 2024 | -60.59% |
April 16, 2024 | -57.68% |
April 15, 2024 | -56.40% |
April 12, 2024 | -54.78% |
April 11, 2024 | -53.15% |
April 10, 2024 | -53.28% |
April 09, 2024 | -52.28% |
April 08, 2024 | -52.00% |
April 05, 2024 | -51.57% |
April 04, 2024 | -52.06% |
April 03, 2024 | -50.18% |
Date | Value |
---|---|
April 02, 2024 | -50.59% |
April 01, 2024 | -46.05% |
March 28, 2024 | -48.52% |
March 27, 2024 | -47.41% |
March 26, 2024 | -47.42% |
March 25, 2024 | -46.04% |
March 22, 2024 | -44.82% |
March 21, 2024 | -47.90% |
March 20, 2024 | -47.01% |
March 19, 2024 | -48.02% |
March 18, 2024 | -48.02% |
March 15, 2024 | -46.83% |
March 14, 2024 | -45.36% |
March 13, 2024 | -40.93% |
March 12, 2024 | -42.60% |
March 11, 2024 | -41.52% |
March 08, 2024 | -42.69% |
March 07, 2024 | -43.65% |
March 06, 2024 | -45.04% |
March 05, 2024 | -47.53% |
March 04, 2024 | -47.58% |
March 01, 2024 | -49.01% |
February 29, 2024 | -50.52% |
February 28, 2024 | -48.03% |
February 27, 2024 | -44.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.06%
Minimum
May 07 2024
679.5%
Maximum
Sep 23 2021
65.00%
Average
19.54%
Median
Sep 17 2020
1 Year Total Returns (Daily) Benchmarks
Amarin Corp PLC | -29.85% |
Jazz Pharmaceuticals PLC | -20.16% |
Iterum Therapeutics PLC | 41.96% |
GH Research PLC | 33.48% |
Mural Oncology PLC | -- |